Uncategorized
calendar_month Nov 20, 2026

UnitedHealth Stock Rebounds After TD Cowen Buy Upgrade: What to Know

UnitedHealth Group Inc. (NYSE:UNH) shares are trading higher on Friday after a recent pullback. Here’s what investors need to know.

TD Cowen Upgrades UnitedHealth to Buy

TD Cowen analyst Ryan Langston upgraded UnitedHealth to Buy from Hold rating on Friday and raised the firm’s price target to $455 from $402.

The analyst sees mid-to-high-teens earnings-per-share growth through at least 2028, supported by improvements in Medicare Advantage benefits, a recovery in OptumHealth and stronger margins across the company’s commercial and Medicaid businesses.

CMS Proposal Weighed on Shares Earlier This Week

UnitedHealth shares had come under pressure earlier this week after the Centers for Medicare & Medicaid Services proposed new anti-fraud measures covering Medicare, Medicaid, the Children’s Health Insurance Program and the Health Insurance Marketplace.

The proposed rule could save taxpayers nearly $90 billion over 10 years, according to CMS. It would introduce closer oversight of healthcare providers, tougher audits of Medicare Advantage risk-adjustment data and potential payment recoveries when medical records do not support reported diagnoses.

For UnitedHealth, the proposed changes could mean greater compliance requirements and potential payment clawbacks across its Medicare Advantage and Part D businesses.

Recent Analyst Views

Other Wall Street analysts have also adjusted their views on UnitedHealth in recent weeks.

On Oct. 27, Wells Fargo analyst Stephen Baxter maintained an Overweight rating but lowered his price target to $487 from $526. Morgan Stanley analyst Erin Wright maintained an Overweight rating on the same day and raised her price target to $531 from $529.

UNH Price Action

UNH Price Action: United Health shares were up 4.33% at $344.80 at the time of publication on Friday, according to Benzinga Pro.

Image: Shutterstock